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Background 
The epithelial-mesenquimal transitions (EMT) are essential for the tumor growing and the metastasi process1. In cancer progression, EMT seems to promote the 
spread of cells from the tumor mass and facilitates tissue invasion by the regulation of matrix metalloproteinase production and alternate  cytoskeleton 
organization2. Many activators of this transition are transcription factors that repress the expression of E-cadherin, such as Snail and Slug 3. In this research, we 
propose to inhibit the expression of Slug and Snail to inhibit metastasis of pancreatic adenocarcinoma. 
Hypothesis 
If we repress the expression of Snail and Slug, we will also repress the 
epithelial-mesenquimal transition. If EMT is not possible, it will inhibit the 
metastatic process in pancreas adenocarcinoma cells. We will use human 
pancreas adenocarcinoma cell lines as a model, as well as a subcutaneous 
pancreatic cancer xenograft tumor model induced in mice or tumor 
intrapancreatic injections in mice. We will foccus in the NF-κB-Snail-RKIP 
pathway. 
Specific aims 
1. The proteasome inhibitor NPI-0052 induces RKIP and inhibits Snail. 
2. Nitric Oxide Inhibits Tumor Cell Metastasis via Dysregulation of the NF-
κB/Snail/RKIP Loop. 
3. (-)-Epigallocatechin 3-gallate inhibits Snail by regulating HDAC activity. 
4. Inhibiting Interactions of Lysine Demethylase LSD1 with Snail/Slug Blocks 
Cancer Cell Invasion. 
Experimental 
Specific aim 1 
•NPI-0052 treatment in human pancreas adenocarcinoma cell lines 
•NPI-0052 treatment and radiation to NUDE mice, with either AsPC-1 xenographt 
or intrapancreatic injection in vivo 
•NPI-0052 inhibits the NF-κB promoter activity 
 
Specific aim 2 
•DETANONOat produces cellular fenotip reversion 
•DETANONOat inhibits SNAIL expression 
•Inhibition of DNA binding activity by Snail 
•Direct role of Snail supression in EMT inhibition 
•NO as a mediator in mesenquimal fenotip reversion from mice cells with 
intrapancreatic injection or carrying MiA-PaCa2 and AsPC-1 xenographt 
 
Specific aim 3 
•EGCG effect in cell death 
•HDAC activity Assay 
 
Specific aim 4 
•Parnate effect in Slug/LSD1 interaction and E-cadherina promoter repression 
dependent on Slug 
•E-cadherina expression in Parnate treated cells 
•Parnate effect in migration, invasion and pancreas adenocarcinoma cell lines 
proliferation 
Societal significance  
Cancer is an illness that has a high impact on the humanbeing in our society. This high impact 
promotes the advancement of essential research for cures to this illness. This research proposal is 
focused on pancreas adenocarcinoma, which has a bad prognosis and has no treatment. We will 
try to inhibit EMT in this type of cancer with this research. We expect to obtain promising results 
to treat patients suffering from pancreas adenocarcinoma. 
 
Possible patentability 
Invention background: Inhibition of Snail and Slug expression to inhibit the pancreas 
adenocarcinoma metastasis.  
Methods and Novelties: Use of proteosome inhibitor NP-0052, NO and Parnate; never used 
before in pancreas adenocarcinoma.  
Aplication: Inhibition of EMT in pancreas adenocarcinoma and, consequently the metastasis 
process. 
 ”Potential Claims” 
1. Snail and Slug inhibition in pancreas adenocarcinoma 
1.1 Use of  proteosome NP-0052 in pancreas adenocarcionma as a Snail inhibitor 
1.2 NO in pancreas adenocarcionma as a Snail inhibitor 
1.3 EGCG in pancreas adenocarcionma as a Snail inhibitor 
1.4 Parnate treatment in pancreas adenocarcionma as a Snail inhibitor 
1.5 Snail inhibition in pancreas adenocarcionma 
Timetable of the project 
 
 
 
 
 
Budget 
 
 
 
 
Methods 
•Real-time PCR: RKIP transcription levels in cells. 
•Weastern Bloot Analysis: Protein expression and genic products indication. 
•Protein Assays: Total level of protein in a solution. 
•EMSA: Protein–DNA or protein–RNA interactions. 
•Clonogenic Assays: Effectiveness of agents on cell survival and proliferation. 
•Different Kits  are explained in the experimental. 
Animals and human cell lines Models 
•Subcutaneous pancreatic cancer xenograft tumor model or 
intrapancreatic tumor injection in NUDE mice (AsPC-1 o MiA-PaCa2) 
•Human pancreas adenocarcinoma cell lines (AsPC-1 cell line) 
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Figure 1. NUDE mice 
with induced pancreas 
adenocarcinoma4 
Figure 2. NF-κB-Snail-RKIP pathway  
Research Proposal 
 Research group 
•Researcher 1 (FTJ) 
•Researcher 2 (FTJ) 
•Researcher 3 (FTJ) 
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